Serum glucose, cholesterol and blood pressure levels in Japanese type 1 and 2 diabetic patients: BioBank Japan

BioBank Japan Cooperative Hospital Group

Research output: Contribution to journalArticle

Abstract

Background: Evidence of characteristics of Japanese patients with diabetes from a large-scale population is necessary. Few studies have compared glycaemic controls, complications and comorbidities between type 1 and 2 diabetic patients. This paper focuses on illustrating a clinical picture of Japanese diabetic patients and comparing glycaemic control and prognoses between type 1 and 2 diabetes using multiinstitutional data. Methods: The BioBank Japan Project enrolled adult type 1 and 2 diabetic patients between fiscal years 2003 and 2007. We have presented characteristics, controls of serum glucose, cholesterol and blood pressure, prevalence of complications and comorbidities and survival curves. We have also shown glycaemic controls according to various individual profiles of diabetic patients. Results: A total of 558 type 1 diabetic patients and 30,834 type 2 diabetic patients participated in this study. The mean glycated haemoglobin A1c was higher in type 1 diabetes than in type 2 diabetes. In the type 1 diabetic patients, the glycated haemoglobin A1c had no consistent trend according to age and body mass index. The KaplaneMeier estimates represented a longer survival time from baseline with type 1 diabetes than with type 2 diabetes. Compared with type 1 diabetic patients, type 2 diabetic patients had double the prevalence of macrovascular complications. Conclusions: This work has revealed detailed plasma glucose levels of type 1 and 2 diabetic patients according to age, body mass index, blood pressure, serum cholesterol levels and smoking and drinking habits. Our data have also shown that the prognosis is worse for type 2 diabetes than for type 1 diabetes in Japan.

Original languageEnglish
Pages (from-to)S92-S97
JournalJournal of epidemiology
Volume27
Issue number3
DOIs
Publication statusPublished - 01-01-2017

Fingerprint

Japan
Cholesterol
Blood Pressure
Glucose
Serum
Type 1 Diabetes Mellitus
Type 2 Diabetes Mellitus
Glycosylated Hemoglobin A
Comorbidity
Body Mass Index
Survival
Drinking
Habits
Smoking
Population

All Science Journal Classification (ASJC) codes

  • Epidemiology

Cite this

@article{d3fd3373873d4548af887c9dbb20954e,
title = "Serum glucose, cholesterol and blood pressure levels in Japanese type 1 and 2 diabetic patients: BioBank Japan",
abstract = "Background: Evidence of characteristics of Japanese patients with diabetes from a large-scale population is necessary. Few studies have compared glycaemic controls, complications and comorbidities between type 1 and 2 diabetic patients. This paper focuses on illustrating a clinical picture of Japanese diabetic patients and comparing glycaemic control and prognoses between type 1 and 2 diabetes using multiinstitutional data. Methods: The BioBank Japan Project enrolled adult type 1 and 2 diabetic patients between fiscal years 2003 and 2007. We have presented characteristics, controls of serum glucose, cholesterol and blood pressure, prevalence of complications and comorbidities and survival curves. We have also shown glycaemic controls according to various individual profiles of diabetic patients. Results: A total of 558 type 1 diabetic patients and 30,834 type 2 diabetic patients participated in this study. The mean glycated haemoglobin A1c was higher in type 1 diabetes than in type 2 diabetes. In the type 1 diabetic patients, the glycated haemoglobin A1c had no consistent trend according to age and body mass index. The KaplaneMeier estimates represented a longer survival time from baseline with type 1 diabetes than with type 2 diabetes. Compared with type 1 diabetic patients, type 2 diabetic patients had double the prevalence of macrovascular complications. Conclusions: This work has revealed detailed plasma glucose levels of type 1 and 2 diabetic patients according to age, body mass index, blood pressure, serum cholesterol levels and smoking and drinking habits. Our data have also shown that the prognosis is worse for type 2 diabetes than for type 1 diabetes in Japan.",
author = "{BioBank Japan Cooperative Hospital Group} and Hiroshi Yokomichi and Akiko Nagai and Makoto Hirata and Yutaka Kiyohara and Kaori Muto and Toshiharu Ninomiya and Koichi Matsuda and Yoichiro Kamatani and Akiko Tamakoshi and Michiaki Kubo and Yusuke Nakamura and Zentaro Yamagata and Sunao Matsubayashi and Michiaki Kubo and Kazuo Misumi and Rieko Komi and Shiro Minami and Hitoshi Sugihara and Naoya Emoto and Akio Kanazawa and Yusuke Suzuki and Yoshimune Hiratsuka and Satoshi Asai and Mitsuhiko Moriyama and Yasuo Takahashi and Tomoaki Fujioka and Wataru Obara and Seijiro Mori and Hideki Ito and Satoshi Nagayama and Yoshio Miki and Akihide Masumoto and Akira Yamada and Yasuko Nishizawa and Ken Kodama and Satoshi Ugi and Hiroshi Maegawa and Yukihiro Koretsune and Hideki Taki and Takeshi Osawa",
year = "2017",
month = "1",
day = "1",
doi = "10.1016/j.je.2016.12.013",
language = "English",
volume = "27",
pages = "S92--S97",
journal = "Journal of Epidemiology",
issn = "0917-5040",
publisher = "Japan Epidemiology Association",
number = "3",

}

Serum glucose, cholesterol and blood pressure levels in Japanese type 1 and 2 diabetic patients : BioBank Japan. / BioBank Japan Cooperative Hospital Group.

In: Journal of epidemiology, Vol. 27, No. 3, 01.01.2017, p. S92-S97.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Serum glucose, cholesterol and blood pressure levels in Japanese type 1 and 2 diabetic patients

T2 - BioBank Japan

AU - BioBank Japan Cooperative Hospital Group

AU - Yokomichi, Hiroshi

AU - Nagai, Akiko

AU - Hirata, Makoto

AU - Kiyohara, Yutaka

AU - Muto, Kaori

AU - Ninomiya, Toshiharu

AU - Matsuda, Koichi

AU - Kamatani, Yoichiro

AU - Tamakoshi, Akiko

AU - Kubo, Michiaki

AU - Nakamura, Yusuke

AU - Yamagata, Zentaro

AU - Matsubayashi, Sunao

AU - Kubo, Michiaki

AU - Misumi, Kazuo

AU - Komi, Rieko

AU - Minami, Shiro

AU - Sugihara, Hitoshi

AU - Emoto, Naoya

AU - Kanazawa, Akio

AU - Suzuki, Yusuke

AU - Hiratsuka, Yoshimune

AU - Asai, Satoshi

AU - Moriyama, Mitsuhiko

AU - Takahashi, Yasuo

AU - Fujioka, Tomoaki

AU - Obara, Wataru

AU - Mori, Seijiro

AU - Ito, Hideki

AU - Nagayama, Satoshi

AU - Miki, Yoshio

AU - Masumoto, Akihide

AU - Yamada, Akira

AU - Nishizawa, Yasuko

AU - Kodama, Ken

AU - Ugi, Satoshi

AU - Maegawa, Hiroshi

AU - Koretsune, Yukihiro

AU - Taki, Hideki

AU - Osawa, Takeshi

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Background: Evidence of characteristics of Japanese patients with diabetes from a large-scale population is necessary. Few studies have compared glycaemic controls, complications and comorbidities between type 1 and 2 diabetic patients. This paper focuses on illustrating a clinical picture of Japanese diabetic patients and comparing glycaemic control and prognoses between type 1 and 2 diabetes using multiinstitutional data. Methods: The BioBank Japan Project enrolled adult type 1 and 2 diabetic patients between fiscal years 2003 and 2007. We have presented characteristics, controls of serum glucose, cholesterol and blood pressure, prevalence of complications and comorbidities and survival curves. We have also shown glycaemic controls according to various individual profiles of diabetic patients. Results: A total of 558 type 1 diabetic patients and 30,834 type 2 diabetic patients participated in this study. The mean glycated haemoglobin A1c was higher in type 1 diabetes than in type 2 diabetes. In the type 1 diabetic patients, the glycated haemoglobin A1c had no consistent trend according to age and body mass index. The KaplaneMeier estimates represented a longer survival time from baseline with type 1 diabetes than with type 2 diabetes. Compared with type 1 diabetic patients, type 2 diabetic patients had double the prevalence of macrovascular complications. Conclusions: This work has revealed detailed plasma glucose levels of type 1 and 2 diabetic patients according to age, body mass index, blood pressure, serum cholesterol levels and smoking and drinking habits. Our data have also shown that the prognosis is worse for type 2 diabetes than for type 1 diabetes in Japan.

AB - Background: Evidence of characteristics of Japanese patients with diabetes from a large-scale population is necessary. Few studies have compared glycaemic controls, complications and comorbidities between type 1 and 2 diabetic patients. This paper focuses on illustrating a clinical picture of Japanese diabetic patients and comparing glycaemic control and prognoses between type 1 and 2 diabetes using multiinstitutional data. Methods: The BioBank Japan Project enrolled adult type 1 and 2 diabetic patients between fiscal years 2003 and 2007. We have presented characteristics, controls of serum glucose, cholesterol and blood pressure, prevalence of complications and comorbidities and survival curves. We have also shown glycaemic controls according to various individual profiles of diabetic patients. Results: A total of 558 type 1 diabetic patients and 30,834 type 2 diabetic patients participated in this study. The mean glycated haemoglobin A1c was higher in type 1 diabetes than in type 2 diabetes. In the type 1 diabetic patients, the glycated haemoglobin A1c had no consistent trend according to age and body mass index. The KaplaneMeier estimates represented a longer survival time from baseline with type 1 diabetes than with type 2 diabetes. Compared with type 1 diabetic patients, type 2 diabetic patients had double the prevalence of macrovascular complications. Conclusions: This work has revealed detailed plasma glucose levels of type 1 and 2 diabetic patients according to age, body mass index, blood pressure, serum cholesterol levels and smoking and drinking habits. Our data have also shown that the prognosis is worse for type 2 diabetes than for type 1 diabetes in Japan.

UR - http://www.scopus.com/inward/record.url?scp=85016395269&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016395269&partnerID=8YFLogxK

U2 - 10.1016/j.je.2016.12.013

DO - 10.1016/j.je.2016.12.013

M3 - Article

C2 - 28162891

AN - SCOPUS:85016395269

VL - 27

SP - S92-S97

JO - Journal of Epidemiology

JF - Journal of Epidemiology

SN - 0917-5040

IS - 3

ER -